Tag: Exosome risks

While often marketed as a miracle cure, a significant issue with exosome therapy is the lack of robust clinical evidence and regulatory oversight from bodies like the FDA, making its safety and efficacy highly uncertain. Here, we explore in detail what are the disadvantages of exosome therapy, covering everything from safety concerns to the financial burden on patients.

Despite the marketing claims, the U.S. Food and Drug Administration (FDA) has issued public safety warnings regarding unapproved exosome products. A critical understanding of the potential downsides and scientific unknowns is necessary to evaluate the true disadvantages of exosome treatment before considering this therapy.